Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Kala Pharmaceuticals Inc (NQ: KALA )

7.100 USD -0.060 (-0.84%)
Streaming Delayed Price Updated: 9:38 AM EDT, Apr 14, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Kala Pharmaceuticals Inc

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Implied IBB Analyst Target Price: $193
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Wave Life Sciences Pulls Plug On 2 Assets, Amarin's Vascepa Snags European Approval, Biocept Jumps On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags Penny Stocks GMAB INVO
From Benzinga
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in... 
From Business Wire News Releases
Kala Pharmaceuticals Announces Preferred Position for EYSUVIS™ on Cigna
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in March
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
Analysts Expect IEIH Will Reach $39
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CTMX LNTH RCEL
From Benzinga
Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported... 
From Business Wire News Releases
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags VIR GKOS HZNP
From Benzinga
Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in... 
From Business Wire News Releases
Kala Pharmaceuticals Announces EYSUVIS™ Now Covered by Express Scripts
Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
Kala Pharmaceuticals (KALA) Shares Cross Above 200 DMA
In trading on Thursday, shares of Kala Pharmaceuticals Inc (KALA) crossed above their 200 day moving average of $9.15, changing hands as high as $9.85 per share. Kala Pharmaceuticals Inc shares are... 
Tags Stocks
From Market News Video
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in... 
From Business Wire News Releases
First Week of March 19th Options Trading For Kala Pharmaceuticals (KALA)
Investors in Kala Pharmaceuticals Inc (KALA) saw new options become available this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the KALA... 
Tags Stocks
From Market News Video
Kala Pharmaceuticals Announces Availability of EYSUVISTM for the Treatment of Dry Eye Disease and Provides Update on Development Pipeline
Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced the... 
From Business Wire News Releases
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in January
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in... 
From Business Wire News Releases
First Week of KALA July 2021 Options Trading
Investors in Kala Pharmaceuticals Inc (KALA) saw new options become available this week, for the July 2021 expiration. One of the key inputs that goes into the price an option buyer is willing to pay,... 
Tags Stocks
From Market News Video
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as inducement awards outside the Company’s 2017 Equity Incentive Plan in... 
From Business Wire News Releases
Kala Pharmaceuticals Provides Update on Launch Plans for EYSUVISTM for the Treatment of Dry Eye Disease
Kala Pharmaceuticals, Inc., (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today provided an... 
From Business Wire News Releases
Kala Pharmaceuticals to Present at the Jefferies 2020 Virtual London Healthcare Conference
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
How The Pieces Add Up: IEIH Headed For $37
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags VCEL Biotech OFIX
From Benzinga
Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate Update
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today reported... 
From Business Wire News Releases
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags OYST ADMS SPRO
From Benzinga
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call
Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that... 
From Business Wire News Releases
52 Biggest Movers From Yesterday
Gainers Scholar Rock Holding Corporation (NASDAQ: SRRK) shares jumped 118.8% to close at $30.02 on Tuesday after the company ... 
Tags EXAS AMKR TTNP
From Benzinga
Notable Tuesday Option Activity: BNFT, VICR, KALA
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Benefitfocus Inc (BNFT), where a total volume of 1,124 contracts has been traded... 
Tags Stocks
From Market News Video
46 Stocks Moving In Tuesday's Mid-Day Session
Gainers Scholar Rock Holding Corporation (NASDAQ: SRRK) gained 82.4% to $25.02 after the company reported proof-of-concept data ... 
Tags Consumer Discretionary BBW FFIV
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.